Creative Graphics exports exceeded FY26 total in H1 FY27
Key highlights
- Creative Graphics reported Rs 12.0 crore of exports in H1 FY27, above Rs 8.1 crore for all of FY26.
- Wahren generated Rs 8.3 crore of H1 FY27 exports, while flexography generated Rs 3.7 crore.
- Creative Graphics targets about 25% of pharma packaging revenue from exports.
- Pharma packaging capacity reached 44,000 MTPA, with all lines in production from October 2026.
powered by IRIS

Creative Graphics Solutions India Limited reported Rs 12.0 crore of exports in H1 FY27, exceeding FY26’s Rs 8.1 crore in six months, while management targets overseas sales at about 25% of pharma packaging revenue. Pharma packaging supplied Rs 8.3 crore of the H1 FY27 export total, following its first export order in February 2026.
Know Creative Graphics Solutions India inside out
Results, valuation, peers and who's buying, in one view.
How much did Creative Graphics export in H1 FY27?
Creative Graphics exported Rs 12.0 crore in H1 FY27, equal to 5.2% of consolidated revenue of Rs 233.3 crore. The total was Rs 3.9 crore higher than the Rs 8.1 crore of exports recorded for the full FY26, when exports represented 2.3% of group revenue.
Pharma packaging subsidiary Wahren contributed Rs 8.3 crore of H1 FY27 exports, while flexography contributed Rs 3.7 crore. The first pharma export order arrived in February 2026, making the Rs 8.3 crore reported by Wahren a result from a recently established export activity.
Creative Graphics’ consolidated revenue rose 32.6% year on year from Rs 175.9 crore in H1 FY26 to Rs 233.3 crore in H1 FY27. Export progress occurred while Middle East conflict-related supply disruption delayed the ramp-up of PVC/PVDC and Tandem lines, as well as the commercial start of the Oman flexography plant.
What is Creative Graphics’ pharma export target?
Creative Graphics is targeting exports of about 25% of pharma packaging revenue, but management has not disclosed an absolute revenue objective or a deadline for achieving it. The presentation also does not state what percentage of Wahren’s current revenue comes from exports.
The export plan is linked to a wider packaging portfolio. Wahren offers Alu Alu foil, polyvinyl chloride and polyvinylidene chloride films, known as PVC/PVDC, extrusion laminates and lidding foils, allowing it to address blister packs, sachets, strip foils and multi-layer packaging requirements.
Creative Graphics also has Drug Master Files, or DMFs, in the USA, China and Canada. Management says generic-drug makers serving regulated markets can reference these regulatory files in their submissions, while Wahren’s qualification process includes supplier audits, customer-line trials, documentation, vendor approval and repeat commercial orders.
The company says export sales earn better price realisations than domestic sales, but it provides no numerical comparison of pricing, gross margin or profitability. H1 FY27 consolidated gross margin was 24.9%, compared with 27.1% in H1 FY26 and 23.5% in H2 FY26.
How is Creative Graphics developing export markets?
Creative Graphics used five industry events in H1 FY27 across India, Jordan, Egypt and Nigeria to develop commercial contacts. The events included Arab Manufacturer in Jordan during July 2026, Pharmaconex in Egypt during September 2026 and Nigeria Pharma Expo in Lagos during September 2026.
Management said it was in discussion with pharma packaging customers in 11 countries during H1 FY27. Its identified markets include Brazil, Russia, Turkey, Jordan, Egypt, Nepal, Bangladesh, Thailand, Sri Lanka and Malaysia, alongside DMF markets in Canada, the USA and China.
The FY26 and H1 FY27 figures cover different durations, but both periods show exhibition activity outside India. Three overseas events were held in H2 FY26, including Pharmapack in Paris in January 2026, Nepal Pharma Expo in Kathmandu in March 2026 and Asia Pharma Expo in Dhaka in March 2026.
Creative Graphics introduced export factoring in H1 FY27 to fund export receivables soon after shipment and offer overseas buyers credit terms. The presentation does not disclose the value of receivables factored, the financing cost or the credit period available to customers.
Got a follow-up? Ask IRIS
What capacity supports Creative Graphics’ export plan?
Creative Graphics has installed 44,000 metric tonnes per annum, or MTPA, of pharma packaging capacity across four lines, with all lines in production from October 2026. This capacity includes 8,000 MTPA of existing Alu Alu capacity and 12,000 MTPA each of PVC/PVDC, Tandem extrusion and new Alu Alu capacity.
The expansion lifted pharma capacity from 8,000 MTPA in FY25 to 44,000 MTPA after the project, a 5.5-fold increase. At 30 September 2026, 32,000 MTPA was in commercial production, before the new 12,000-MTPA Alu Alu line began commercial production in October 2026 following August trials.
The PVC/PVDC coating line began commercial production in H2 FY26, while the Tandem extrusion line began in April 2026. The Tandem line produces three-to-five-ply extrusion laminates used in sachets, strip foils and multi-layer packs, extending Wahren beyond its established Alu Alu offering.
Creative Graphics reported more than 350 active pharma clients and quality systems including Good Manufacturing Practice, or GMP, ISO, BRC and SGS. Management says all planned capital expenditure is complete, leaving customer approvals, product volumes and utilisation as the disclosed operating priorities for the new lines.
What could affect Creative Graphics’ export ramp-up?
Creative Graphics’ export development is occurring while new capacity and plants carry costs ahead of full volumes. H1 FY27 earnings before interest, tax, depreciation and amortisation, or EBITDA, was Rs 19.5 crore, down 7.2% year on year from Rs 21.0 crore, although it rose 56.6% from Rs 12.4 crore in H2 FY26.
EBITDA margin was 8.3% in H1 FY27, compared with 11.9% in H1 FY26 and 7.3% in H2 FY26. Management attributed the year-on-year decline to capacity ramp-up and supply-chain disruption, while employee expenses increased 41.7% to Rs 18.1 crore and other expenses rose 48.5% to Rs 20.6 crore.
Working-capital funding also increased as revenue grew. Trade receivables rose from Rs 114.2 crore in March 2026 to Rs 173.3 crore in September 2026, while inventory increased from Rs 55.7 crore to Rs 73.5 crore over the same period.
Short-term borrowings rose from Rs 62.0 crore in March 2026 to Rs 114.5 crore in September 2026. Creative Graphics said the Rs 37.4 crore increase in total borrowings funded receivables and inventory, while the Oman flexography plant remained installed but awaiting commercial start because of war-related supply-chain and manpower challenges.
Conclusion
Creative Graphics’ Rs 12.0 crore of H1 FY27 exports exceeded its full-year FY26 total, with Wahren contributing Rs 8.3 crore after beginning pharma exports in February 2026. The export effort combines DMFs in three regulated markets, overseas exhibitions, export factoring and a broader packaging range supported by 44,000 MTPA of installed pharma capacity.
The next items to watch are utilisation and commercial volumes from the PVC/PVDC, Tandem and new Alu Alu lines, as well as progress toward management’s target of about 25% of pharma packaging revenue from exports. Management also identifies the pending commercial start of the Oman plant, intended to serve Gulf and African packaging converters, as an unresolved operating milestone.


